Cargando…

Factors predicting radiation pneumonitis in locally advanced non-small cell lung cancer

PURPOSE: Thoracic radiotherapy is a major treatment modality of stage III non-small cell lung cancer. The normal lung tissue is sensitive to radiation and radiation pneumonitis is the most important dose-limiting complication of thoracic radiation therapy. This study was performed to identify the cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Myungsoo, Lee, Jihae, Ha, Boram, Lee, Rena, Lee, Kyung-Ja, Suh, Hyun Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Radiation Oncology 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429901/ https://www.ncbi.nlm.nih.gov/pubmed/22984669 http://dx.doi.org/10.3857/roj.2011.29.3.181

Ejemplares similares

Long-term results of forward intensity-modulated radiation therapy for patients with early-stage breast cancer
por: Ha, Boram, et al.
Publicado: (2013)

Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer
por: Mayahara, Hiroshi, et al.
Publicado: (2022)

Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis
por: Kawahara, Daisuke, et al.
Publicado: (2021)

Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer
por: Inoue, Hiroto, et al.
Publicado: (2020)

Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer
por: Hayashi, Kazuhiko, et al.
Publicado: (2017)

Radiation Pneumonitis in Association with Internal Mammary Node Irradiation in Breast Cancer Patients: An Ancillary Result from the KROG 08-06 Study
por: Choi, Jinhyun, et al.
Publicado: (2016)

Abnormal pulmonary function tests predict the development of radiation-induced pneumonitis in advanced non-small cell lung Cancer
por: Torre-Bouscoulet, L., et al.
Publicado: (2018)

Bilateral diffuse grade 5 radiation pneumonitis after intensity modulated radiation therapy for localized lung cancer
por: Osborn, Virginia W, et al.
Publicado: (2017)

Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung Cancer
por: Torresan, Sara, et al.
Publicado: (2023)

Usefulness of Simple Original Interstitial Lung Abnormality Scores for Predicting Radiation Pneumonitis Requiring Steroidal Treatment After Definitive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
por: Kashihara, Tairo, et al.
Publicado: (2020)

Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer
por: Hassanzadeh, Comron, et al.
Publicado: (2020)

Incidence and dose-volume relationship of radiation pneumonitis after concurrent chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancer
por: Saito, Satoshi, et al.
Publicado: (2020)

The impact of age on the survival outcomes and risk of radiation pneumonitis in patients with unresectable locally advanced non-small cell lung cancer receiving chemoradiotherapy
por: Zhang, Tao, et al.
Publicado: (2020)

Cytokine Profiles of Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy with Regards to Radiation Pneumonitis Severity
por: Jeong, Bae Kwon, et al.
Publicado: (2021)

Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics?
por: Thomas, Hannah M. T., et al.
Publicado: (2022)

Interstitial Lung Change in Pre-radiation Therapy Computed Tomography Is a Risk Factor for Severe Radiation Pneumonitis
por: Lee, Yun Hee, et al.
Publicado: (2015)

A Magnetic Resonance-based Seed Localization Method for I-125 Prostate Implants
por: Lee, Rena J., et al.
Publicado: (2007)

Pneumonitis in advanced non-small cell lung cancer: no interaction between immune checkpoint inhibition and radiation therapy
por: Neibart, Shane S., et al.
Publicado: (2023)

Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung Cancer
por: Kim, Kyeong-Hyun, et al.
Publicado: (2013)

Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy
por: Kim, Kangpyo, et al.
Publicado: (2017)

Predictive Factors for Radiation Pneumonitis in Lung Cancer Treated with Helical Tomotherapy
por: Kim, Youngkyong, et al.
Publicado: (2013)

Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer
por: Castillo, Richard, et al.
Publicado: (2014)

Treatment outcomes after adjuvant radiotherapy following surgery for patients with stage I endometrial cancer
por: Kim, Jiyoung, et al.
Publicado: (2016)

Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer
por: Nishimura, Ari, et al.
Publicado: (2021)

Left Ventricular Systolic Dysfunction Is a Possible Independent Risk Factor of Radiation Pneumonitis in Locally Advanced Lung Cancer Patients
por: Cai, Guoxin, et al.
Publicado: (2020)

Nivolumab‐induced radiation recall pneumonitis in non‐small‐cell lung cancer patients with thoracic radiation therapy
por: Noda‐Narita, Shoko, et al.
Publicado: (2022)

Ipsilateral lung dose volume parameters predict radiation pneumonitis in addition to classical dose volume parameters in locally advanced NSCLC treated with combined modality therapy
por: Agrawal, Sushma, et al.
Publicado: (2014)

Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Atezolizumab Post Chemo-Radiation
por: Saade, Lili Jose, et al.
Publicado: (2023)

Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab
por: Diamond, Brett H., et al.
Publicado: (2022)

Radiomic and Dosiomic Features for the Prediction of Radiation Pneumonitis Across Esophageal Cancer and Lung Cancer
por: Puttanawarut, Chanon, et al.
Publicado: (2022)

Function-Wise Dual-Omics analysis for radiation pneumonitis prediction in lung cancer patients
por: Li, Bing, et al.
Publicado: (2022)

Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer
por: Yue, Jinbo, et al.
Publicado: (2017)

Analysis of predictive parameters for the development of radiation-induced pneumonitis
por: Yamagishi, Toru, et al.
Publicado: (2017)

The TGF-β1 dynamics during radiation therapy and its correlation to symptomatic radiation pneumonitis in lung cancer patients
por: Kim, Ji-Yoon, et al.
Publicado: (2009)

Radiation Pneumonitis with Eosinophilic Alveolitis in a Lung Cancer Patient
por: Hosono, Yuki, et al.
Publicado: (2017)

Curcumin Mitigates Radiation-induced Lung Pneumonitis and Fibrosis in Rats
por: Amini, Paiman, et al.
Publicado: (2018)

Afatinib-Induced Acute Fatal Pneumonitis in Metastatic Lung Adenocarcinoma
por: Yoo, Sang Hoon, et al.
Publicado: (2016)

Hypofractionated Radiotherapy Dose Scheme and Application of New Techniques Are Associated to a Lower Incidence of Radiation Pneumonitis in Breast Cancer Patients
por: Lee, Byung Min, et al.
Publicado: (2020)

Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy
por: Shi, Anhui, et al.
Publicado: (2010)

Radiation pneumonitis in patients with non-small-cell lung cancer receiving chemoradiotherapy and an immune checkpoint inhibitor: a retrospective study
por: Jang, Jeong Yun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0dr7mm5mgh7tnk8ld7khhuumct